We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Intrauterine Surgery Dramatically Boosts Fetal Survival Rate

By HospiMedica International staff writers
Posted on 27 Dec 2011
A new study reveals that fetal tracheal occlusion (FETO) improves infant survival rate in severe cases of congenital diaphragmatic hernia (CDH). More...


Researchers at the University of Sao Paulo (USP; Brazil) conducted a randomized trial between May 2008 and July 2010 to compare the safety and efficacy of FETO for the treatment of severe isolated CDH. In all, 20 patients were assigned randomly to undergo FETO and 21 patients were assigned to no prenatal intervention (control group). FETO was performed under maternal epidural anesthesia supplemented with fetal intramuscular anesthesia; tracheal balloon placement with ultrasound guidance and fetoscopy was completed between 26 and 30 weeks of gestation. The primary outcome was survival to 6 months of age, and other maternal and neonatal outcomes were also evaluated.

The results showed that delivery occurred at a mean 35.6 weeks in the FETO group and at 37.4 weeks in the control group. In all, 50% of the infants in the FETO group and one infant out of 21 (4.8%) in the control group survived, a ten-fold increase in infant survival rate. According to the researchers, the FETO procedure appears to improve survival by enhancing pulmonary growth as a consequence of fetal tracheal occlusion. The study was published in the December 14, 2011, issue of Ultrasound in Obstetrics & Gynecology.

“The present study allows the establishment of this treatment as standard care for severe forms of congenital diaphragmatic hernia,” concluded lead author Rodrigo Ruano, MD, PhD, and colleagues of the department of obstetrics and gynecology.

CDH is a congenital malformation of the diaphragm that allows the abdominal organs to enter the chest cavity and interfere with proper lung formation. The most common type of CDH is a Bochdalek hernia; other types include Morgagni's hernia, diaphragm eventration, and central tendon defects of the diaphragm. CDH is a life-threatening pathology in infants, and a major cause of death due to two complications: pulmonary hypoplasia and pulmonary hypertension. Newborns with CDH often have severe respiratory distress, which can be life threatening unless treated appropriately.

Related Links:
University of Sao Paulo



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.